Banaji N, Oommen S
Department of Microbiology, IGMC and RI, Pondicherry - 605 009, India.
Indian J Med Microbiol. 2011 Jul-Sep;29(3):209-12. doi: 10.4103/0255-0857.83901.
Antimicrobial policy for prophylactic and therapeutic use of antimicrobials in a tertiary care setting has gained importance. A hospital's antimicrobial policy as laid down by its hospital infection control team needs to include inputs from the microbiology laboratory, besides the pharmacy and therapeutic committee. Therefore, it is of utmost importance that clinical microbiologists across India follow international guidelines and also take into account local settings, especially detection and presence of resistance enzymes. This article draws a framework for rational antimicrobial testing in our laboratories in tertiary care centers, from the Clinical and Laboratory Standards Institute guidelines. It does not address testing methodologies but suggests ways and means by which antimicrobial susceptibility reporting can be rendered meaningful not only to the treating physician but also to the resistance monitoring epidemiologist. It hopes to initiate some standardization in rational choice of antimicrobial testing in laboratories in the country pertaining to nonfastidious bacteria.
在三级医疗环境中,抗菌药物预防性和治疗性使用的抗菌政策变得越发重要。医院感染控制团队制定的医院抗菌政策,除了药房和治疗委员会的意见外,还需要纳入微生物实验室的意见。因此,印度各地的临床微生物学家遵循国际指南并考虑当地情况,尤其是耐药酶的检测和存在情况至关重要。本文根据临床和实验室标准协会的指南,为我们三级医疗中心实验室的合理抗菌检测制定了一个框架。它没有涉及检测方法,而是提出了一些方法和途径,通过这些方法,抗菌药物敏感性报告不仅要对治疗医生有意义,而且要对耐药性监测流行病学家有意义。它希望在该国实验室针对非苛养菌的抗菌检测合理选择方面启动一些标准化工作。